“…Characterized by rapid progression, early metastasis, and resistance to conventional therapies, pancreatic cancer has long posed a significant clinical challenge ( 15 ). Recent research efforts have expanded our comprehension of the intricate molecular alterations and the complex tumor microenvironment driving its pathogenesis ( 16 ). Advances in early detection methods, targeted therapies, and immunotherapies have emerged as promising avenues for combating pancreatic cancer, offering renewed hope for improved patient outcomes ( 17 ).…”